Core Viewpoint - Guangku Technology plans to acquire 100% equity of Jabil Technology (Wuhan) Co., Ltd. for a consideration of $17 million plus adjustments based on the target company's net cash and transaction costs, aiming to enhance its competitive strength in the optical module sector [1][2]. Group 1: Acquisition Details - The acquisition agreement was signed on June 3, and it does not require shareholder approval but needs regulatory approvals [1]. - The acquisition price of $17 million is approximately 122 million RMB based on the exchange rate on June 4 [2]. - Guangku Technology intends to finance the acquisition using its own funds [2]. Group 2: Strategic Rationale - The target company, Wuhan Jabil, has comprehensive manufacturing capabilities in optical devices and strong customer resources, which complement Guangku Technology's product offerings [2]. - The acquisition is expected to optimize the customer structure, enrich the product line, and expand production scale, thereby achieving strategic synergy [2]. Group 3: Financial Performance - In 2024, Wuhan Jabil is projected to achieve revenue of 241 million RMB and a net profit of approximately 6.52 million RMB [3]. - For the first quarter of this year, Wuhan Jabil reported revenue of 64.17 million RMB and a net profit of 878,400 RMB [3]. - Guangku Technology is expected to achieve nearly 1 billion RMB in revenue and a net profit of 66.98 million RMB in 2024 [4].

Group 1 - Xunlei has completed the acquisition of Hupu's operating company, Shanghai Kuanghui Network Technology Co., Ltd., with an initial cash payment of 400 million RMB and two subsequent payments of 100 million RMB each over the next 24 months [3] - NIO's subsidiary, LeDao, is piloting a high-end ride-hailing service in a limited area, targeting users similar to those of Didi's premium service, as clarified by NIO's regional manager [5] - Xiaopeng Motors announced a strategic partnership with Huawei, planning to integrate Huawei's HUD solution into its new vehicles, indicating a significant innovation in the automotive industry [6][7] Group 2 - High合 (Gaohe) Automotive's Guangzhou branch has been restricted from high consumption due to failure to fulfill financial obligations in a labor dispute, with an outstanding amount of approximately 384,000 RMB [9]

6月2日，迅雷发布公告称，其已完成对匡慧的收购，后者运营着国内体育媒体和数据平台虎扑。根据迅 雷与匡慧的最终协议条款，迅雷已在交割前支付了4亿元的现金对价。如先前所宣布，交易的总现金代 价为5亿元。根据最终协议的条款，迅雷将分别在交易完成后的12个月和24个月后，分两期等额支付剩 余的人民币1亿元现金对价。 公开资料介绍，迅雷成立于2003年，主要提供跨云加速、共享云计算和数字娱乐的广泛产品和服务。从 财报中来看，其去年总营收为3.24亿美元，同比下滑11.1%，其中，会员业务收入为1.34亿美元，同比 增长12%。今年一季度，其总营收为8880万美元，同比增长10.5%，其中，会员业务收入为3570万美 元，同比增长7.7%。 迅雷已在交割前支付了4亿元的现金对价。根据最终协议的条款，迅雷将分别在交易完成后的12个月和 24个月后，分两期等额支付剩余的人民币1亿元现金对价。 迅雷完成对虎扑的5亿元收购 迅雷的整体业务由于国内直播业务缩减以及云计算业务收入减少而一定程度上承压，但会员收入依旧是 其核心优势板块。而从目前情况中来看，迅雷用户数不及虎扑。财报数据显示，截至今年一季度，迅雷 会员数超600万，而早在 ...

6月4日，据中国新闻网，近日， 深圳市迅雷网络技术有限公司发布公告称，已完成对上海旷晖网络 科技有限公司的收购，后者运营着体育媒体和数据平台虎扑。 来源：九派新闻综合中国新闻网等 该公告称，根据迅雷与旷晖的最终协议条款，迅雷已在交割前支付了4亿元的现金对价。如先前所宣 布， 交易的总现金代价为人民币5亿元。 根据最终协议的条款，迅雷将分别在交易完成后的12个月和24个月后，分两期等额支付剩余的人民 币1亿元现金对价。 此前，据界面新闻， 迅雷有限公司于2025年1月27日宣布，与虎扑的运营方上海匡慧互联网科技有 限公司达成协议，计划以人民币5亿元现金收购该公司。交易预计将在2025年上半年完成。 迅雷董事长兼CEO李金波表示，收购虎扑将使迅雷与之形成强大的协同效应。这一战略举措将充分发 挥迅雷在互联网内容传输领域的庞大用户基础和技术优势，同时结合虎扑的优质体育内容和活跃社 区，促进内容下载、社区互动以及忠实用户群体中的体育消费。此外，收购还将丰富迅雷的内容生态 系统，增强社区运营，并通过迅雷的技术和品牌优势提升整体用户体验。 图源：VCG 迅雷官网显示，该公司成立于2003年，曾推出迅雷下载、迅雷云盘等产品。 ...

飞亚达：拟现金收购陕西长空齿轮有限公司控股权 智通财经6月4日电，飞亚达(000026.SZ)公告称，公司与汉中汉航机电有限公司签署股权收购意向协 议，拟以现金方式收购陕西长空齿轮有限责任公司的全部或部分控股权。汉航机电为公司实际控制人中 国航空工业集团有限公司的控股子企业，本次交易构成关联交易。长空齿轮主营研发、设计、生产和销 售精密齿轮及相关产品，若本次收购顺利完成，有助于增强公司精密科技业务的技术实力和核心能力。 ...

苏垦农发（601952）公告，公司拟使用自有资金，以现金为对价，通过特定事项协议转让方式受让金太 阳（300606）粮油股东陈洁、滕晓梅、丛红芬、陈曙燕、袁建军、朱国良、周献忠、郑建和南通七龙合 计持有的金太阳粮油2300万股(占比28.75%)无限售条件股份，交易价格为7.72元/股，交易总价款为1.78 亿元。交易完成后，公司将持有金太阳粮油6400万股股份，占总股本的80%。本次交易事项已经公司第 五届董事会第七次会议审议通过，尚需取得全国中小企业股份转让系统有限公司出具的确认函等。 ...

Group 1 - elf Beauty Inc announced a $1 billion acquisition of Rhode, a skincare brand founded by Hailey Bieber, which is expected to enhance its skincare offerings and attract higher-income consumers [1] - The acquisition news coincided with a strong fiscal fourth-quarter earnings report, where elf Beauty reported adjusted earnings of 78 cents per share on $333 million in revenue, surpassing Wall Street expectations [1] - The company withheld full-year guidance due to uncertainties related to tariffs [1] Group 2 - Following the acquisition announcement, elf Beauty's stock surged 31.1% to $118.63, marking its highest level since January and reducing its year-to-date deficit to 6% [2] - The stock has experienced a nearly 90% increase in the past month and has reclaimed its 200-day moving average, which had been a resistance level since last August [2] Group 3 - At least four analysts raised their price targets for elf Beauty, with Canaccord Genuity increasing its target from $105 to $114, indicating potential for further upward revisions [3] - The average 12-month target for the stock is $99.22, suggesting a nearly 10% discount to current trading levels [3] Group 4 - Options activity for elf Beauty is significantly high, with over 25,000 calls and 21,000 puts exchanged, which is 13 times the average intraday volume [4] - New positions are being opened at nine of the ten most active contracts, led by the weekly 5/30 110-strike put [4]

Policy Developments - The National Medical Products Administration (NMPA) held a meeting on May 28 to discuss the "Clearing Source" action in the drug distribution sector, emphasizing strict enforcement of regulations and collaboration across departments to ensure drug quality and safety [2]. Drug and Device Approvals - Novartis announced on May 28 that its anti-VEGF monoclonal antibody, Brolucizumab, has been approved by the NMPA for the treatment of diabetic macular edema (DME), allowing for injections every three months after the loading phase [4]. - On the same day, the NMPA accepted the new drug application (NDA) for Rocbrutinib, a fourth-generation BTK inhibitor developed by LuPeng Pharmaceutical, which is intended for adult patients with mantle cell lymphoma (MCL) who have previously received BTK inhibitor treatment [5]. Capital Market Activities - Zhenmai Bio completed a C+ round financing of 280 million yuan on May 28, with participation from multiple investors, aiming to focus on "commercial ecosystem construction" and "global expansion" [7]. Industry Events - On May 27, Anmai Bio announced a global licensing agreement with Juri Biosciences for the development of KLK2 and CD3 T-cell engaging molecules for metastatic prostate cancer, with potential payments up to 210 million USD [9]. - Eli Lilly announced on May 27 that it will acquire SiteOne Therapeutics, a startup focused on developing sodium channel inhibitors for pain management, with a total deal value of up to 1 billion USD [10]. Regulatory and Compliance Issues - ST Longjin announced on May 28 that it received a decision from the Shenzhen Stock Exchange to terminate its stock listing, effective June 27, 2025, due to non-compliance with listing rules [12]. - ST Jiyuan's stock will be delisted on May 29, 2025, after failing to maintain a closing price above 1 yuan for 20 consecutive trading days [14]. - ST Suwu reported on May 28 that it is under investigation by the China Securities Regulatory Commission (CSRC) for information disclosure violations, but its daily operations remain normal [15]. - Jiaying Pharmaceutical announced on May 28 that it is under investigation by the CSRC for suspected information disclosure violations and will cooperate with the regulatory body [16].

据知情人士透露，英国石油公司（BP）的Castrol润滑油业务吸引到Reliance Industries Ltd.等能源公司的 的收购意向。 阿波罗和Lone Star Funds等买断公司也感兴趣。（彭博） ...